MMV, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999.
Our mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.
Our vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.
MMV was established as a foundation in 1999, and registered in Switzerland. Today, it is a leading product development partnership (PDP) in the field of antimalarial drug research and development.
MMV has evolved from a four-person start-up, to an organisation with more than 40 staff members. See our current job vacancies.
See more background information and resources related to malaria and antimalarial medicines.
MMV is run by an experienced management team and governed by a Board of Directors. Expert advisory committees provide guidance in the fields of science, global safety and access and delivery.
Meet MMV's staff, experts in their fields, with a wide range of professional and international backgrounds.
MMV has received sustained funding and support from public and private donors. This has been augmented by substantial in-kind contributions from our research partners.
